Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Immune Therapy of Multiple Sclerosis - Future Strategies.
Vitamin d and multiple sclerosis.
Synthesis and biological evaluation of tyrosine modified analogues of the α4β7 integrin inhibitor biotin-R(8)ERY.
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
Falls and physical activity in persons with multiple sclerosis.
The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
Incidence and distribution of extravascular compression of extracranial venous pathway in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis.
Children with multiphasic disseminated encephalomyelitis and antibodies to the myelin oligodendrocyte glycoprotein (MOG): Extending the spectrum of MOG antibody positive diseases.
Experience with Fingolimod in Clinical Practice.
Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
The role of information system in multiple sclerosis management.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
R PheWAS: Data Analysis and Plotting Tools for Phenome Wide Association Studies in the R Environment.
The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages.
Atrophy and structural variability of the upper cervical cord in early multiple sclerosis.
Upper extremity function and its relation with hand sensation and upper extremity strength in patients with multiple sclerosis.
Could behavioral therapies target specific deficits in multiple sclerosis patients?
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Optic Neuritis, its Differential Diagnosis and Management.
Neurons and T cells: Understanding this interaction for inflammatory neurological diseases.
Antigen Microarrays for the Study of Autoimmune Diseases.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Sodium channels in astroglia and microglia.
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life.
Pages
« first
‹ previous
…
260
261
262
263
264
265
266
267
268
…
next ›
last »